Mast cells and angiogenesis in gastric carcinoma

International Journal of Experimental Pathology

Volumn 91, Issue 4, 2010, Pages 350-356

  Ribatti, Domenico ^a   Guidolin, Diego ^b   Marzullo, Andrea ^c   Nico, Beatrice ^a   Annese, Tiziana ^a   Benagiano, Vincenzo ^a   Crivellato, Enrico ^d  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^c UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^d UNIVERSITY OF UDINE   (Italy)

Author keywords

angiogenesis; chymase; gastric cancer; mast cells; tryptase; tumour progression

Indexed keywords

CD31 ANTIGEN; CHYMASE; TRYPTASE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GASTRECTOMY; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; ANTIGENS, CD31; CHYMASES; FEMALE; GASTRECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAST CELLS; MICROVESSELS; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; STOMACH NEOPLASMS; TRYPTASES;

EID: 77955077945     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2010.00714.x     Document Type: Article

References (52)

1. Araya M., Terashima M., Takagane A. et al. (1997) Microvessel count predicts metastasis and prognosis in patients with gastric cancer. J. Surg. Oncol. 65, 232 236.
2. Benítez-Bribiesca L., Wong A., Utrera D., Castellanos E. (2001) The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J. Histochem. Cytochem. 49, 1061 1062.
3. Blair R.J., Meng H., Marchese M.J. et al. (1997) Tryptase is a novel, potent angiogenic factor. J. Clin. Invest. 99, 2691 2700.
4. Bowrey P.F., King J., Magarey C. et al. (2000) Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect? Br. J. Cancer 82, 167 170.
5. Elpek G.O., Gelen T., Aksoy N.H. et al. (2001) The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. J. Clin. Pathol. 54, 940 944.
6. Etoh T., Inoue H., Tanaka S., Barnard G.F., Kitano S., Mori M. (2001) Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res. 61, 2145 2153.
7. Gasparini G., Longo R., Toi M., Ferrara N. (2005) Angiogenic inhibitors: a new therapeutic strategy in oncology. Nat. Clin. Pract. Oncol. 2, 562 577.
8. Glowacki J. Mulliken J.B. (1982) Mast cells in hemangiomas and vascular malformations. Pediatrics 70, 48 51.
9. Graham R.M. Graham J.B. (1996) Mast cells and cancer of the cervix. Surg. Gynecol. Obstet. 123, 3 9.
10. Gruber B.L., Marchese M.J., Suzuki K. et al. (1989) Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J. Clin. Invest. 84, 1657 1662.
11. Guidolin D., Crivellato E., Nico B., Andreis P.G., Nussdorfer G.G., Ribatti D. (2006) An image analysis of the spatial distribution of perivascular mast cells in human melanoma. Int. J. Mol. Med. 17, 981 987.
12. Guidolin D., Zunarelli E., Genedani S. et al. (2008) Opposite patterns of age-associated changes in neurons and glial cells of the thalamus of human brain. Neurobiol. Aging 29, 926 936.
13. Kanai T., Konno H., Tanaka T. et al. (1998) Anti-tumor and anti-metastatic effects of human-vascular-endothelial-growth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice. Int. J. Cancer 77, 933 936.
14. Kitadai Y., Haruma K., Sumii K. et al. (1998) Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am. J. Pathol. 152, 93 100. (Pubitemid 28028050)
15. Kitadai Y., Takahashi Y., Haruma K. et al. (1999) Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br. J. Cancer 81, 647 653.
16. Lachter J., Stein M., Lichtig C., Eidelman S., Munichor M. (1995) Mast cells in colorectal neoplasias and premalignant disorders. Dis. Colon Rectum 38, 290 293.
17. Maeda K., Chung Y.S., Takatsuka S. et al. (1995) Tumor angiogenesis as a predictor of occurrence in gastric carcinoma. J. Clin. Oncol. 13, 477 481.
18. Maeda K., Chung Y.S., Ogawa Y. et al. (1996) Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77, 858 863.
19. Maehara Y., Kabashima A., Koga T. et al. (2000) Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery 128, 408 416.
20. McCarty M.F., Wey J., Stoeltzing O. et al. (2004) ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer. Mol. Cancer Ther. 3, 1041 1048.
21. Molica S., Vacca A., Crivellato E., Cuneo A., Ribatti D. (2003) Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia. Eur. J. Haematol. 71, 137 139. (Pubitemid 36951650)
22. Mukheriee S., Bandyopadhyay G., Dutta C., Bhattacharya A., Karmakar R., Barui G. (2009) Evaluation of endoscopic biopsy in gastric lesions with a special reference to the significance of mast cell density. Indian J. Pathol. Microbiol. 52, 20 24.
23. Ribatti D. Crivellato E. (2009a) Immune cells and angiogenesis. J. Cell Mol. Med. 13, 2822 2833.
24. Ribatti D. Crivellato E. (2009b) The controversial role of mast cells in tumor growth. Int. Rev. Cell. Mol. Biol. 275, 89 131.
25. Ribatti D. Vacca A. (2008) Overview of angiogenesis during tumor growth. In : Angiogenesis: An Integrative Approach from Science to Medicine, pp. 161 168 (eds W.D. Figg, J. Folkman
26. Ribatti D., Nico B., Vacca A. et al. (1998) Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas? Br. J. Cancer 77, 1900 1906.
27. Ribatti D., Vacca A., Nico B. et al. (1999) Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br. J. Cancer 79, 451 455.
28. Ribatti D., Vacca A., Marzullo A. et al. (2000) Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int. J. Cancer 85, 171 175.
29. Ribatti D., Polimeno G., Vacca A. et al. (2002) Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes. Leukemia 16, 1680 1684.
30. Ribatti D., Marzullo A., Nico B., Crivellato E., Ria R., Vacca A. (2003a) Erythropoietin as an angiogenic factor in gastric carcinoma. Histopathology 42, 246 250.
31. Ribatti D., Vacca A., Ria R. et al. (2003b) Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur. J. Cancer 39, 666 674.
32. Ribatti D., Ennas M.G., Vacca A. et al. (2003c) Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur. J. Clin. Invest. 33, 420 425.
33. Ribatti D., Molica S., Vacca A. et al. (2003d) Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia 17, 1428 1430. (Pubitemid 36857360)
34. Ribatti D., Crivellato E., Roccaro A.M., Ria R., Vacca A. (2004) Mast cell contribution to angiogenesis related to tumor progression. Clin. Exp. Allergy 34, 1660 1664.
35. Ribatti D., Finato N., Crivellato E. et al. (2005) Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am. J. Obstet. Gynecol. 193, 1961 1965.
36. Ribatti D., Nico B., Vacca A. (2006) Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene 25, 4257 4266.
37. Ribatti D., Nico B., Crivellato E., Roccaro A.M., Vacca A. (2007) The history of the angiogenic switch concept. Leukemia 21, 44 52.
38. Saito H., Tsujitani S., Oka S. et al. (1999) The expression of transforming growth factor-α-1 is significantly correlated with the expression of vascular endothelial growth factor and prognosis of patients with advanced gastric carcinoma. Cancer 86, 1455 1462.
39. Sawatsubashi M., Yamada T., Fukushima N., Mizokami H., Tokunaga O., Shin T. (2000) Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch. 436, 243 248.
40. Schwartz L.B. (2006) Analysis of MC(T) and MC(TC) mast cells in tissue. Methods Mol. Biol. 315, 53 62.
41. Shah M.A., Ramanathan R.K., Ilson D.H. et al. (2006) Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma. J. Clin. Oncol. 24, 5201 5206.
42. Stack M.S. Johnson D.A. (1994) Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J. Biol. Chem. 269, 9416 9419.
43. Taiplae J., Lohi J., Saarinen J., Kovanen P.T., Keshi-Oja J. (1995) Human mast cell chymase and leukocyte elestase release latent transforming growth factor beta-1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 270, 4689 4696.
44. Takahashi Y., Cleary K.R., Mai M., Kitadai Y., Bucana C.D., Ellis L.M. (1996) Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin. Cancer Res. 2, 1679 1684.
45. Takahashi Y., Bucana C.D., Akagi Y. et al. (1998) Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer. Clin. Cancer Res. 4, 429 434.
46. Tanigawa N., Amaya H., Matsumura M. et al. (1996) Extent of tumor vascularization correlates with prognosis and hematogeneous metastasis in gastric carcinomas. Cancer Res. 56, 2671 2676.
47. Tanigawa N., Amaya H., Matsumura M., Shimomatsuya T. (1997a) Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric cancer. J. Clin. Oncol. 15, 826 832.
48. Tanigawa N., Amaya H., Matsumura M., Shimomatsuya T. (1997b) Association of tumour vasculature with tumour progression and overall survival of patients with non-early gastric carcinomas. Br. J. Cancer 75, 566 571.
49. Tokuyama J., Kubota T., Saikawa Y. et al. (2005) Tyrosine kinase inhibitor SU6668 inhibits peritoneal dissemination of gastric cancer via suppression of tumor angiogenesis. Anticancer Res. 25, 17 22.
50. Tomita M., Matsuzaki Y., Onitsuka T. (2000) Effect of mast cells on tumor angiogenesis in lung cancer. Ann. Thorac. Surg. 69, 1686 1690.
51. Tóth-Jakatics R., Jimi S., Takebayashi S., Kawamoto N. (2000) Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. Hum. Pathol. 31, 955 960.
52. Zhang H., Wu J., Meng L., Shou C.C. (2002) Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells. World J. Gastroenterol. 8, 994 998.